Express Healthcare

Lupin Digital Health launches digital heart failure clinic in India

0 361

The Lyfe Digital Heart Failure (HF) Clinic has been developed to address the growing burden on healthcare infrastructure due to increasing heart failure instances in India

Lupin Digital Health (LDH) has announced the launch of its newest offering, Lyfe Digital Heart Failure Clinic in India. This e-clinic aims to help cardiologists and caregivers manage heart failure patients effectively from the comfort of their homes.

The Lyfe Digital Heart Failure (HF) Clinic has been developed to address the growing burden on healthcare infrastructure due to increasing heart failure instances in India. It combines in-clinic consultation with at-home patient monitoring and care. A team of experts, including paramedics, nurses, cardiotherapists, health coaches and care managers, work together with the treating cardiologist to deliver improved patient health outcomes. The system is equipped with advanced technology, providing doctors with real-time updates and patients with personalised care pathways, emergency services and educational resources.

Commenting on the launch, Rajeev Sibal, President-India Region Formulations, Lupin Limited, said, “The launch of Lyfe Digital HF clinic is a significant milestone in transforming cardiac care in India. We would like to partner with every cardiologist in India, augmenting them with a multidisciplinary team of experts to help them better manage their heart failure patients.  Our solution combines AI-guided software and FDA/CE-approved devices to provide clinically actionable alerts and insights.”

Sidharth Srinivasan, CEO, Lupin Digital Health said, We are thrilled to introduce the Lyfe Digital HF Clinic solution in India, a pioneering solution that brings cardiac care right to the homes of patients. Our aim is to support cardiologists and caregivers in effectively managing heart failure, ensuring improved health outcomes for patients. The initial results of this new initiative have been encouraging, with 88 per cent compliance, improved biovitals, and reduced re-hospitalisation. We are committed to making this innovative solution accessible to as many patients as possible through collaborations with cardiologists and hospitals.”

 

 

 

 

 

 

- Advertisement -

Leave A Reply

Your email address will not be published.